Reflect Scientific, Inc. (RSCF)
0.0454
-0.01
(-12.36%)
USD |
OTCM |
Aug 25, 16:00
Reflect Scientific Price to Book Value : 1.598 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.598 |
| August 24, 2026 | 1.823 |
| August 21, 2026 | 1.827 |
| August 20, 2026 | 1.752 |
| August 19, 2026 | 1.752 |
| August 18, 2026 | 1.752 |
| August 17, 2026 | 1.752 |
| August 14, 2026 | 1.654 |
| August 13, 2026 | 1.830 |
| August 12, 2026 | 1.549 |
| August 11, 2026 | 1.359 |
| August 10, 2026 | 1.359 |
| August 07, 2026 | 1.373 |
| August 06, 2026 | 1.373 |
| August 05, 2026 | 1.338 |
| August 04, 2026 | 1.348 |
| August 03, 2026 | 1.359 |
| July 31, 2026 | 1.390 |
| July 30, 2026 | 1.461 |
| July 29, 2026 | 1.549 |
| July 28, 2026 | 1.443 |
| July 27, 2026 | 1.426 |
| July 24, 2026 | 1.426 |
| July 23, 2026 | 1.503 |
| July 22, 2026 | 1.478 |
| Date | Value |
|---|---|
| July 21, 2026 | 1.478 |
| July 20, 2026 | 1.443 |
| July 17, 2026 | 1.434 |
| July 16, 2026 | 1.434 |
| July 15, 2026 | 1.415 |
| July 14, 2026 | 1.506 |
| July 13, 2026 | 1.417 |
| July 10, 2026 | 1.417 |
| July 09, 2026 | 1.51 |
| July 08, 2026 | 1.443 |
| July 07, 2026 | 1.443 |
| July 06, 2026 | 1.492 |
| July 02, 2026 | 1.478 |
| July 01, 2026 | 1.478 |
| June 30, 2026 | 1.408 |
| June 29, 2026 | 1.464 |
| June 26, 2026 | 1.537 |
| June 25, 2026 | 1.537 |
| June 24, 2026 | 1.467 |
| June 23, 2026 | 1.467 |
| June 22, 2026 | 1.61 |
| June 18, 2026 | 1.654 |
| June 17, 2026 | 1.654 |
| June 16, 2026 | 1.741 |
| June 15, 2026 | 1.775 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| West Pharmaceutical Services, Inc. | 8.191 |
| Agilent Technologies, Inc. | 6.094 |
| Anika Therapeutics, Inc. | 2.056 |
| Bio-Rad Laboratories, Inc. | 1.452 |
| Bruker Corp. | 3.645 |
Price to Book Value Related Metrics
| PE Ratio | 11.95 |
| PS Ratio | 2.190 |
| PEG Ratio | 0.0869 |
| Price to Free Cash Flow | 21.94 |
| Price | 0.0454 |
| Earnings Yield | 8.37% |
| Market Cap | 3.889M |
| PEGY Ratio | 0.0869 |
| Operating PE Ratio | 14.43 |
| Normalized PE Ratio | 11.95 |